FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Federal Register

Animal Drug Regs Amended for Approvals

Federal Register notice: FDA amends its animal drug regulations to reflect application-related actions for made during January, February, and March.

latest-news-card-1
Medical Devices

Expiry Dates Extended on CTK Bios Covid Tests

FDA says CTK Biotechs ImmuView Covid-19 Antigen Home Test now has a longer shelf life than previously authorized.

latest-news-card-1
Human Drugs

Ascendis Pharma NDA Review Extended

FDA extends by three months its review of an Ascendis Pharma NDA for TransCon PTH (palopegteriparatide) due to the companys submission of additional i...

latest-news-card-1
Human Drugs

FDA OKs Expanded Clinolipid Use

FDA approves Baxters expanded indication for parenteral (intravenous) nutritient Clinolipid (lipid injectable emulsion) for use in pediatric patients,...

latest-news-card-1
Medical Devices

Respironics Recall of Trilogy Evo Ventilators

Philips Respironics recalls (Class 1) its Trilogy Evo continuous ventilator devices due to a software issue that may cause a power malfunction.

latest-news-card-1
Human Drugs

Novo Nordisk Filing BLA for Hemophilia A Drug

Novo Nordisk says it will seek FDA approval by the end of the year for Mim8, its next-generation Factor 8a mimetic bispecific antibody for once-weekly...

latest-news-card-1
Human Drugs

Merus Breakthrough Status for Petosemtamab

FDA grants Merus a breakthrough therapy designation for petosemtamab for treating certain patients with recurrent or metastatic head and neck squamous...

latest-news-card-1
Medical Devices

Warning on Cue Healths Covid Tests

FDA issues a warning for healthcare providers and consumers not to use Cue Healths Covid-19 tests due to the increased risk of false results.

latest-news-card-1
Human Drugs

Eugia Sent 7-Item 483 After India Inspection

FDA issues Eugia Pharma Specialties (an Aurobindo subsidiary) a seven-item Form-483 following a 5/3-concluded inspection at its sterile drug manufactu...

latest-news-card-1
Human Drugs

FDA Priority Review for Dupixent sBLA

FDA accepts for priority review a Regeneron Pharmaceuticals and Sanofi supplemental BLA for Dupixent (dupilumab) as an add-on maintenance treatment fo...